Literature DB >> 30098159

Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma.

Brian Claggett1, Lu Tian2, Lee-Jen Wei3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30098159      PMCID： PMC7020856          DOI： 10.1001/jamaoncol.2018.3483

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  A comparison of statistical methods for meta-analysis.

Authors:  S E Brockwell; I R Gordon
Journal:  Stat Med       Date:  2001-03-30       Impact factor: 2.373

2.  Confidence intervals for random effects meta-analysis and robustness to publication bias.

Authors:  Masayuki Henmi; John B Copas
Journal:  Stat Med       Date:  2010-10-20       Impact factor: 2.373

3.  Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.

Authors:  Kyongsun Pak; Hajime Uno; Dae Hyun Kim; Lu Tian; Robert C Kane; Masahiro Takeuchi; Haoda Fu; Brian Claggett; Lee-Jen Wei
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

4.  Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis.

Authors:  Binod Dhakal; Aniko Szabo; Saurabh Chhabra; Mehdi Hamadani; Anita D'Souza; Saad Z Usmani; Rita Sieracki; Bishal Gyawali; Jeffrey L Jackson; Fotis Asimakopoulos; Parameswaran N Hari
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.